Wockhardt Aims for Global Debut of New Meningitis Drug with $6 Billion Market Potential by 2026
Wockhardt is set to launch its breakthrough meningitis drug, WCK 5222 (Zaynich), by 2026, targeting a $6 billion market.
Justpep.com is a place where you can share your Story/ Product/ Review/ Profile URL and get noticed by the world.
Your ads here